Drug Discovery to Development Innovation Forum Sponsors
InterAx Biotech AGInterAx Biotech AG is a Swiss based spin-off company from the ETH Zurich and the Paul Scherrer Institute (PSI). The core expertise of InterAx resides in the combination of cell-based real-time assays and proprietary computational algorithms that enable intelligent drug candidate design and selection targeting G protein coupled receptors (GPCRs).
PHABIOCPHABIOC is the Pharma Business Unit of InnoME GmbH, which was founded in 2015. PHABIOC develops novel tools (e.g. innovative artificial membranes, microtiter plates and analytical devices) for small scale studies and high throughput screenings in the pharmaceutical and biotechnology industries. Our products are characterized by the fact that they provide a direct customer benefit through more modern and effective analysis options.